Advisor Net Financial, Inc Ligand Pharmaceuticals Inc Transaction History

Advisor Net Financial, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$69.53 - $79.33 $69 - $79	1 Added 100.0%	2 $0
Q4 2022 Jan 13, 2023	BUY	$61.72 - $96.74 $61 - $96	1 New	1 $0
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $3,199 - $3,748	-33 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$107.38 - $129.34 $3,543 - $4,268	33 New	33 $4,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.